Tariffs will keep prices firm in the first half of 2026, squeezing purchasing power for low- and middle-income households
A GLP-1 microdosing chart may help guide gradual dose titration, potentially reducing tolerability challenges that some patients experience
Unlike treatments designed specifically for weight management, BPC-157 does not seem to: Reduce appetite Increase feelings of fullness Trigger fat burning Significantly increase calorie expenditure Instead, any potential weight-related benefits are generally believed to occur indirectly through improvements in recovery, mobility, and overall physical function
This discussion about Federal Reserve independence
However, ten or more additional generic manufacturers may launch in 2025 providing a true, low-cost alternative GLP-1
Overall, this produces a net decrease in adipose tissue and a net energy consumption (i.e